Rheopheresis as therapeutic option in patients with recurring sudden sensorineural hearing loss refractory to standard therapy

Selma Uygun-Kiehne, Richard Straube, Andreas Heibges, Reinhard Klingel & Heino Davids
Background and objective: For patients suffering from recurring sudden hearing loss (SHL) refractory to standard infusion therapy, new therapeutic options have to be established. LDL-fibrinogen apheresis, covering Rheopheresis and HELP-apheresis for the indication of SHL, has been shown to be equally[for full text, please go to the a.m. URL]